Apollo Hospitals Conducts India’s First Ultra RESILIA Valve Implantation

Quick Summary

• Event: India’s first implantation of the Edwards SAPIEN 3 Ultra RESILIA transcatheter aortic valve (TAVI) was successfully conducted at Apollo Hospitals, Chennai.
• Patient Details: The procedure was performed on a 70-year-old patient with severe calcific tricuspid aortic stenosis who had previously undergone stent placement and was considered high-risk for open-heart surgery.
• Technology: the Edwards SAPIEN 3 Ultra RESILIA valve is designed to last longer, resist calcification, and reduce the need for repeat procedures.
• Procedure: It was carried out in a minimally invasive manner by Dr. G.sengottuvelu, senior interventional cardiologist at Apollo Hospitals.
• Statements from Authorities:

– Dr. Sengottuvelu highlighted that this marks “a new chapter in cardiac care” with benefits including safer outcomes and extended durability of replacement valves.
– Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Group, emphasized the significance of introducing durable and minimally invasive solutions in healthcare.

Indian Opinion Analysis

the triumphant deployment of advanced cardiac technology such as the Edwards SAPIEN 3 Ultra RESILIA transcatheter valve represents an crucial milestone for cardiovascular care in India. As non-invasive procedures become increasingly preferred for high-risk patients like this one, breakthroughs like this can redefine treatment standards across hospitals nationwide.

However, while this technological innovation offers transformative potential-extending durability and enhancing patient safety-the benefits will reach their full impact only if accessibility becomes widespread beyond metropolitan centers like Chennai. Increased national dissemination may depend crucially on addressing issues like affordability and infrastructural capabilities at smaller institutions.

This achievement not only showcases India’s growing expertise in adopting cutting-edge medical technologies but also highlights opportunities to improve long-term health outcomes through continued investment into minimally invasive solutions across broader demographic groups.

read more: [Link to original article]